Dow Down 0.78% Nasdaq Down 1.13%

More On BBP2.SG

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Vernalis plc (BBP2.SG)

-Stuttgart
0.73 Up 0.13(22.13%) Mar 11
Prev Close:N/A
Open:0.62
Bid:0.60 x 1000000
Ask:0.66 x 3333300
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.60 - 0.62
52wk Range:0.60 - 1.25
Volume:26
Avg Vol (3m):N/A
Market Cap:325.49M
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Headlines

  • No Headlines available for BBP2.SG at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vernalis plc, a research and development stage pharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products for various medical disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback